Detalhe da pesquisa
1.
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.
Cardiovasc Drugs Ther
; 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607535
2.
A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension.
Lung
; 201(6): 565-569, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957388
3.
Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis.
J Intensive Care Med
; 37(4): 441-458, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611981
4.
Long-term tolerability of phosphodiesterase-5 inhibitors in pulmonary hypertension of sickle cell disease.
Eur J Haematol
; 107(1): 54-62, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650125
5.
Exploring Tai Chi Exercise and Mind-Body Breathing in Patients with COPD in a Randomized Controlled Feasibility Trial.
COPD
; 18(3): 288-298, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34106027
6.
Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis.
Lung
; 198(3): 535-545, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367414
7.
A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
Mol Pharm
; 15(5): 1954-1963, 2018 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29634905
8.
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic SclerosisRelated Pulmonary Hypertension.
Cardiovasc Drugs Ther
; 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36662449
9.
Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.
Br J Haematol
; 169(6): 887-98, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907665
10.
The effect of anticoagulant choice on venous thromboembolism recurrence and bleeding in sickle cell disease.
Am J Hematol
; 95(10): E279-E281, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619024
11.
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.
Am J Respir Crit Care Med
; 189(6): 727-40, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628312
12.
The Association of Anticoagulation Intensity with Outcomes in Hospitalized COVID-19 Patients.
Adv Hematol
; 2024: 8838308, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500844
13.
Cluster analysis identifies novel real-world lung disease-pulmonary hypertension subphenotypes: implications for treatment response.
ERJ Open Res
; 10(3)2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38770008
14.
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.
Lancet Haematol
; 11(5): e345-e357, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554715
15.
Commentary: Heterogeneity of respiratory disease in children and young adults with sickle cell disease.
Thorax
; 73(6): 503, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353255
16.
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension.
Haematologica
; 98(9): 1359-67, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585527
17.
A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis.
Arthritis Care Res (Hoboken)
; 75(7): 1462-1468, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678779
18.
Role of Left Ventricular Dysfunction in Systemic Sclerosis-Related Pulmonary Hypertension.
Chest
; 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38128607
19.
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
Blood
; 115(9): 1815-22, 2010 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20018918
20.
Prostacyclin-analog therapy in sickle cell pulmonary hypertension.
Haematologica
; 102(5): e163-e165, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126964